Aclarion, Inc. Stock

Equities

ACON

US6551872012

Biotechnology & Medical Research

Delayed Nasdaq 09:42:30 2024-05-15 EDT 5-day change 1st Jan Change
0.279 USD -2.79% Intraday chart for Aclarion, Inc. -8.46% -91.28%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 78K 106K Sales 2025 * - Capitalization 2.35M 3.21M
Net income 2024 * -5M -6.82M Net income 2025 * -5M -6.82M EV / Sales 2024 * 30.2 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-0.25 x
P/E ratio 2025 *
-0.55 x
Employees 5
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.79%
1 week-8.46%
Current month-7.03%
1 month-8.85%
3 months-84.06%
6 months-94.47%
Current year-91.28%
More quotes
1 week
0.27
Extreme 0.2706
0.31
1 month
0.27
Extreme 0.2706
0.69
Current year
0.27
Extreme 0.2668
6.75
1 year
0.27
Extreme 0.2668
25.60
3 years
0.27
Extreme 0.2668
64.80
5 years
0.27
Extreme 0.2668
64.80
10 years
0.27
Extreme 0.2668
64.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-09-14
Director of Finance/CFO 61 21-09-30
Corporate Officer/Principal 52 21-09-14
Members of the board TitleAgeSince
Director/Board Member 67 15-12-31
Chairman 59 20-08-31
Director/Board Member 52 22-04-20
More insiders
Date Price Change Volume
24-05-15 0.279 -2.79% 166 819
24-05-14 0.287 +0.95% 339,211
24-05-13 0.2843 +2.78% 197,375
24-05-10 0.2766 -7.74% 390,309
24-05-09 0.2998 -1.64% 120,526

Delayed Quote Nasdaq, May 15, 2024 at 09:42 am

More quotes
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.287 USD
Average target price
1.5 USD
Spread / Average Target
+422.65%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW